Dual-energy X-ray Absorptiometry (DEXA) Market Size - By Technology (Axial DEXA Bone Densitometer, Peripheral DEXA Bone Densitometer), By Type, By Application, By End-use – Global Forecast to 2032

Dual-energy X-ray Absorptiometry (DEXA) Market Size

Dual-Energy X-Ray Absorptiometry (DEXA) market size was valued at USD 563.2 million in 2022 and is estimated to account for USD 1,219.7 million by 2032. Dual-energy x-ray absorptiometry (DEXA) is a medical imaging technique used to measure and analyze the density of bone and body composition. This system is used to assess bone health, especially for diagnosing osteoporosis and monitoring changes in bone density over time.
 

DEXA scans work by directing two separate X-ray beams as each beam have different energy levels through the body. One beam is absorbed by soft tissues and the other by bone. The amount of each X-ray beam that is absorbed allows for the calculation of bone mineral density (BMD) and other body composition measurements. The DEXA market is witnessing substantial progression opportunities owing to the increasing prevalence of osteoporosis, rising demand for advanced medical imaging services for early disease diagnosis, and advancements in medical technology. These devices offer several advantages such as in early disease diagnosis, decreased risk of radiation exposure, and improved treatment outcomes.
 

Advancements in densitometry technology will enhance the development of more sophisticated and precise devices. Advanced DEXA devices offer enhanced precision and accuracy in the diagnosis of osteoporosis as well as monitoring bone density changes over time period. Moreover, modern DEXA systems incorporate lower-dose radiation technology to minimize radiation exposure to patients while maintaining image quality. This will expand patient preference and enhance the adoption rate over the analysis timeframe. Integration of advanced software solutions into DEXA systems to provide better comprehensive analysis further stimulates market expansion. These software offers several additional parameters such as body composition, body fat measurement, and lean mass. This expanded functionality to increase the utility of DEXA in various healthcare settings including sports medicine, nutrition assessment, and obesity management.
 

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the dual-energy x-ray absorptiometry (DEXA) market in 2020. During the initial phases of the pandemic, several healthcare facilities had to divert resources and personnel to respond to the surge in COVID-19 cases. Non-urgent medical procedures including DEXA scans were postponed or canceled to allocate resources for COVID-19 patients. Also, patient visits reduced due to fear of exposure to the virus. This hesitancy resulted in reduced demand for DEXA devices. Moreover, the global supply chain for medical equipment and supplies faced disruptions due to lockdown, restrictions on international trade, and increased demand for essential healthcare equipment.
 

Dual-energy X-ray Absorptiometry (DEXA) Market Trends

The rising incidence of osteoporosis and vitamin D deficiency will lead to a higher demand for bone health assessment including DEXA scans thereby, impelling product demand. For instance, according to the International Osteoporosis Foundation, around one in three women and one in five men over the age of 50 are suffering from osteoporosis. The organization also estimated that over 75 million patients are associated with osteoporosis in the U.S., Europe, and Japan. Additionally, the study also predicted that osteoporosis is highly underdiagnosed in the Asia region that leads to the risk of fracture. As DEXA systems are proactively used for diagnosing osteoporosis identifying individuals at risk of fractures due to low bone density.
 

Dual-energy X-ray Absorptiometry (DEXA) Market Analysis

The dual-energy x-ray absorptiometry (DEXA) market by technology is segregated into axial DEXA bone densitometer and peripheral DEXA bone densitometer. The axial DEXA bone densitometer garnered more than USD 305.6 million in revenue size in the year 2022. Ongoing technological advancements to enhance the precision and efficiency of axial DEXA scans, reducing radiation exposure and offer broader applications including whole-body composition assessment and paediatric bone health evaluation. High adoption of Axial DEXA systems in research activities and clinical trials related to osteoporosis and fractures will contribute to segmental demand. Moreover, integration of electronic health records (EHR) and telemedicine platforms into axial DEXA systems streamlines data management, enhances patient care coordination and remote interpretation of scans extending access to underserved areas.

Based on type, the dual-energy x-ray absorptiometry (DEXA) market is classified into standalone and portable. The standalone segment accounted for over 59% market share in the year 2022. The substantial surge in the prevalence of osteoporosis due to an aging population and the growing prevalence of risk factors such as fractures. As the number of patients with osteoporosis increases, the demand for dual-energy x-ray absorptiometry (DEXA) for diagnostic procedures will grow substantially in the forthcoming years. Further, increasing awareness among physicians regarding the benefits and effectiveness of DEXA scans led to greater adoption of the product in healthcare settings. Further, several manufacturers are focusing on patient-centric designs for standalone DEXA systems that offer quieter scanning, open configurations, and improved ergonomics will contribute to enhanced patient comfort and reduced anxiety during the procedure.
 

Based on application, the dual-energy x-ray absorptiometry (DEXA) market is subdivided into osteoporosis, body composition analysis, fracture management, bone densitometry, and others. The osteoporosis segment is anticipated to witness substantial expansion at 8.1% CAGR by 2032. The growing prevalence rate of osteoporosis coupled with an increase in the geriatric population that is highly susceptible to bone-related diseases. For instance, as per the Centers for Disease Control and Prevention, more than 18.8% women aged 50 years are suffering from osteoporosis of lumber spine and femur neck in the U.S.
 

Based on end-use, the dual-energy x-ray absorptiometry (DEXA) market is segregated into hospitals & clinics, diagnostic centers, specialty centers, and others. The hospitals & clinics segment is predicted to witness the highest progression to reach over USD 531 million by 2032 attributed to the growing hospital admissions, aging demographics, and high prevalence rate of osteoporosis. Moreover, growing investment in advanced DEXA systems that offer precise bone density assessments and better patient care among facilities. Further, the rising preference for DEXA systems among developed nations due to the high number of obese people that are actively seeking accurate body composition analysis to manage obesity, malnutrition, and other health conditions.
 

U.S. dual-energy x-ray absorptiometry (DEXA) market accounted for USD 197.6 million in revenue size in 2022. The increasing usage of advanced medical technology in healthcare systems, as well as the expanding burden of chronic diseases are some of the major factors driving the U.S. DEXA industry gains. For instance, the American Cancer Society estimated that more than 3,910 new instances of bone and joint cancer in the U.S. in 2022, out of which 1,750 were female patient and over 2,160 were male patients. Since cancer cells and cancer-specific medications have negative effects on bone cells, cancer is a major cause of bone loss and fractures.
 

Dual-energy X-ray Absorptiometry (DEXA) Market Share

Some of the prominent industry participants operating in the dual-energy x-ray absorptiometry (DEXA) market include :

• GE Healthcare,
• Hologic, Inc.
• OSTEOSS
• DMS
• Swissray Medical AG
•  Medilink International,
• ingaoyi
• Osteometer Meditech Inc.
• Fonar Corporation
• Shenzhen XRAY Electric Co., Ltd
• Medonica Co., Ltd.
• Furuno Electric Co., Ltd.
• BeamMed Ltd.,
• Scanflex Healthcare AB 
   

Dual-energy X-ray Absorptiometry (DEXA)Industry News:

• In February 2022, Aurora Spine partnered with Echolight Medical, the manufacturer of the radiation-free EchoS portable densitometer utilized to assess the quality of the software platform and the bone mineral density (BMD) in the patients affected. The two companies decided to advertise one other's products to their respective clients and prospects as part of the Aurora DEXA Platform.
   
• In May 2019, Hologic Inc., partnered with DEXA+ for distribution of its Horizon DXA system for body composition measurement including total lean mass, body fat percentage, and limb comparison to detect muscle imbalances. Through this partnership, Hologic broadened its customer base in the significant market.
   

Dual-energy X-ray absorptiometry (DEXA) market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and in terms of volume in Units from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Technology (USD Million)

• Axial DEXA bone densitometer
• Peripheral DEXA bone densitometer

By Type (USD Million & Units)

• Standalone
• Portable

By Application (USD Million)

• Osteoporosis
• Body composition analysis
• Fracture management
• Bone densitometry
• Others

By End-use (USD Million)

• Hospitals & clinics
• Diagnostic centers
• Specialty centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey